Tesamorelin × Instant Peptides — Lab Test, February 2026
freedomdiagnosticstesting.com publishes a public verification portal. Any test attributed to this lab can be looked up and confirmed directly with the lab — so this result doesn't rest on our review alone.
This certificate carries no lookup code.
Test results
This is a purity and identity analysis. Sterility, endotoxins, and heavy metals were not screened — a high purity figure says nothing about those.
About this test
Label 10 mg · Lab measured 10.77 mg
108% of label, basis not stated — shown as printed. Reconstituted with 2 mL, a 50-unit draw holds 2.7 mg using the measured mass, against 2.5 mg on the label — 8% more.
One vial from this lot was weighed by the laboratory, not yours. This page reports what the certificate says; it does not recommend a dose.
Independent HPLC purity analysis of Tesamorelin from Instant Peptides, performed by freedomdiagnosticstesting.com on February 3, 2026. Reported purity: 99.08%. Net content: 10.77 mg against 10 mg labeled (108% of label). Endotoxins: ≤0.05 EU/mL. Batch 2026-0299-B. Sample source: shop-provided. Certificate of analysis attached.
Certificate of analysis
Other lots of Tesamorelin from Instant Peptides
| Lot | Tested | Lab | Purity | vs label | Status |
|---|---|---|---|---|---|
| 2026-0310-A | 20 May 2026 | Kovera Labs | 99.706% | 113% | Unverified |
| 2026-0239-B | 18 May 2026 | Kovera Labs | 99.884% | 107% | Unverified |
| 2026-0299-C | 6 Feb 2026 | freedomdiagnosticstesting.com | 99.39% | 120% | Unverified |
| 2026-0299-A | 8 Jan 2026 | freedomdiagnosticstesting.com | 99.23% | 120% | Unverified |
| 2025-0299-A | 21 Nov 2025 | freedomdiagnosticstesting.com | 99.261% | 111% | Unverified |
| 2025-0299-C | 4 Sept 2025 | freedomdiagnosticstesting.com | 99.48% | 101% | Unverified |
Batches this shop has published a certificate for, newest first. A lot whose printed value cannot identify a batch is not listed.
Have you tested this peptide?
Submit your third-party lab test to help the community verify purity claims. Every report is reviewed before publication.
Community discussion